The echinocandins: three useful choices or three too many?

International Journal of Antimicrobial Agents
A M Bal

Abstract

Echinocandins act by inhibiting 1,3-beta-D-glucan synthesis in the fungal cell wall. The three licensed agents in this class, namely anidulafungin, caspofungin and micafungin, have a favourable pharmacological profile. These agents are narrow spectrum with clinically relevant activity against Candida and Aspergillus spp. Several trials have established the non-inferiority of these agents over existing agents in the treatment of invasive fungal infections. Caspofungin is also licensed for empirical antifungal therapy of presumed fungal infections in patients with febrile neutropenia. This paper reviews the literature on echinocandins.

References

Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A VillanuevaC A Sable
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Apr 16, 2002·Clinical Therapeutics·Elizabeth A StoneHarold L Kirschenbaum
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Gordon RamageJosé L López-Ribot
Oct 4, 2002·The American Journal of Medicine·Alvaro VillanuevaCarole A Sable
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
Jul 4, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Johan Maertens, Marc Boogaerts
Oct 3, 2003·Diagnostic Microbiology and Infectious Disease·Dimitrios P KontoyiannisIssam I Raad
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GlasmacherIngo G H Schmidt-Wolf
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Matthew K SchinabeckMahmoud A Ghannoum
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David S KrauseTimothy Henkel
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Julie A StoneScott A Waldman
Nov 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Pranab K Mukherjee, Jyotsna Chandra
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jan 14, 2005·Journal of Clinical Pharmacology·James A DowellIrving E Weston
Jan 28, 2005·The New England Journal of Medicine·Dimitrios P Kontoyiannis, Russell E Lewis
Aug 27, 2005·The Journal of Antimicrobial Chemotherapy·Axel Glasmacher, Archibald Grant Prentice
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Kathrin HeynFrank-Michael C Müller
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H Chandrasekar, J D Sobel
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan PachlUNKNOWN Mycograb Invasive Candidiasis Study Group
Dec 21, 2006·Infection·C CheungM Feldmesser
Jan 9, 2007·International Journal of Antimicrobial Agents·Matthew E FalagasGeorge Samonis
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
May 8, 2007·Lancet·Ernst-Rüdiger KuseUNKNOWN Micafungin Invasive Candidiasis Working Group
Jun 15, 2007·The New England Journal of Medicine·Annette C ReboliUNKNOWN Anidulafungin Study Group
Jun 27, 2007·Cornea·Faruk OzturkNuri Kiraz
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasDonald N Buell
Sep 28, 2007·The New England Journal of Medicine·Scott K Aberegg, James M O'Brien
Dec 18, 2007·The Journal of Infection·Graeme N ForrestJennifer K Johnson
Dec 25, 2007·Pharmacotherapy·Benjamin D BrielmaierDavid J Ritchie
Apr 9, 2008·Antimicrobial Agents and Chemotherapy·Melissa J JacobsonRobin Patel
Apr 15, 2008·The Journal of Antimicrobial Chemotherapy·Estelle CateauChristine Imbert
Apr 30, 2008·Antimicrobial Agents and Chemotherapy·Bharat DamleJames Dowell
Jun 17, 2008·Diagnostic Microbiology and Infectious Disease·Eveline van AsbeckDavid A Stevens

❮ Previous
Next ❯

Citations

Mar 7, 2013·Applied Microbiology and Biotechnology·Tamás EmriIstván Pócsi
Sep 13, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L A Vale-SilvaE Pinto
Feb 11, 2011·Current Infectious Disease Reports·Maurizio SanguinettiBrunella Posteraro
Apr 14, 2011·European Journal of Medical Research·A Mayr, Cornelia Lass-Flörl
Dec 24, 2010·Drugs·Sharon C-A ChenTania C Sorrell
May 7, 2011·Journal of Oral Microbiology·David Williams, Michael Lewis
Dec 24, 2013·Future Medicinal Chemistry·Nicolas DelattinKarin Thevissen
Jun 14, 2015·Expert Review of Anti-infective Therapy·Kaat De CremerKatrijn De Brucker
Feb 10, 2016·International Journal of Antimicrobial Agents·Sandra Gil-AlonsoGuillermo Quindós
Mar 19, 2011·Drug Discovery Today·Simon J Teague
Mar 1, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M A PfallerUNKNOWN CLSI Subcommittee for Antifungal Testing
Jun 15, 2011·Mycoses·Astrid MayrCornelia Lass-Flörl
Jun 4, 2016·Journal of Basic Microbiology·Almudena Aranda-MartinezLuis Vicente Lopez-Llorca
Jun 6, 2014·ACS Medicinal Chemistry Letters·Shengzheng WangChunquan Sheng
Aug 23, 2020·Journal of Fungi·Kyle McEvoyMaurizio Del Poeta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.